8-Bromo-3-methyl-xanthine
8-Bromo-3-methyl-xanthine can be used for the synthesis of Linagliptin (L465900. Linagliptin is a novel potent and selective dipeptidyl peptidase-4 inhibitor with potential use in the treatment of type 2 diabetes.
| Catalog Number | INT93703243 |
| Alternative Name(s) | 8-Bromo-3-methyl-3,7-dihydro-1H-purine-2,6-dione;8-bromo-3-methyl-2,3,6,7-tetrahydro-1H-purine-2,6-dione;8-Bromo-3-methyl-7H-purine-2,6-dione;8-bromo-3-methyl-1H-purine-2,6(3H,7H)-dione;8-broMo-3-Methyl-1H-purine-2,6(3H,7H);1H-purine-2,6-dione, 8-broMo-3,7-dihydro-3-Methyl-;3-Methyl-8-broMoxanthine |
| Research Area | Intermediates |
| Molecular Formula | C6H5BrN4O2 |
| CAS# | 93703-24-3 |
| Purity | 0.97% |
| Size | inquiry |
| Supplier Page | https://www.protheragen-ing.com/8-bromo-3-methyl-xanthine-item-6599.html |